Cargando…
Correlates of Vaccine-Induced Protection against SARS-CoV-2
We are in the midst of a pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the coronavirus disease 2019 (COVID-19). SARS-CoV-2 has caused more than two million deaths after one year of the pandemic. The world is experiencing a deep economic reces...
Autores principales: | Koch, Till, Mellinghoff, Sibylle C., Shamsrizi, Parichehr, Addo, Marylyn M., Dahlke, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035658/ https://www.ncbi.nlm.nih.gov/pubmed/33801831 http://dx.doi.org/10.3390/vaccines9030238 |
Ejemplares similares
-
Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial
por: Shamsrizi, Parichehr, et al.
Publicado: (2021) -
Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens
por: Weskamm, Leonie M., et al.
Publicado: (2022) -
SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Mellinghoff, Sibylle C., et al.
Publicado: (2021) -
2343. SARS-CoV-2 Spike Conformation Essentially Influences Vaccine Immunogenicity – Results from Two Clinical Phase I Trials of the Vector Vaccine Candidates MVA-SARS-2-S and MVA-SARS-2-ST
por: Fathi, Anahita, et al.
Publicado: (2023) -
SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)